Podcast Episodes
Back to Search
Episode 484: ASCO GU 2026 - LITESPARK 022: Adjuvant Pembro + Belzutifan in RCC
This in-depth discussion explores the latest advancements in adjuvant kidney cancer treatment, focusing on the recent phase 3 trial results of belzut…
7 months, 3 weeks ago
Episode 482: ASCO GU 2026 - SUNRISE 2
The conversation revolves around the Sunrise 2 trial, a study investigating the efficacy of TAR-200 combined with cetrilimab versus traditional chemo…
7 months, 3 weeks ago
Episode 483: ASCO GU 2026 - KEYNOTE B15: Neoadjuvant EVP vs Gem/Cis in Cis-eligible MIBC
In this podcast , Brian, Tom and Matt Galsky discuss the B15 study data on neoadjuvant therapy for muscle invasive bladder cancer, focusing on the ef…
7 months, 4 weeks ago
Episode 480: ASCO GU 2026 - PEACE-3 and BRCAway Final OS Results
In this episode, Evan Yu discusses the latest prostate cancer data presented at ASCO GU, focusing on the final overall survival results of the PEACE …
7 months, 4 weeks ago
Episode 479: Does the Timing of IO Infusion Impact Clinical Outcomes? A Critical Analysis
This episode critically examines a recent Nature Medicine paper on the timing of immune therapy infusion in lung cancer, exploring the scientific pla…
8 months ago
Episode 478: Prostate Cancer Working Group 4 (PCWG 4) criteria
Summary
This Uromigos podcast delves into the evolution and significance of the Prostate Cancer Working Group criteria, highlighting the iterative pro…
8 months, 1 week ago
Episode 477: Uromigos Japan - GU Oncology 2025を総括!
3人で前立腺癌、腎癌、尿路上皮癌の2025をレビューしました。
8 months, 2 weeks ago
Episode 476: ASCO GU 2026 Preview
In this podcast , the Uromigos discuss the upcoming ASCO GU conference. They delve into the latest research findings, including phase 3 trials, combi…
8 months, 2 weeks ago
Episode 475: Depth of Response and Overall Survival for IO-based Regimens in mRCC: Results of an FDA Analysis
In this Uromigos podcast episode, Brian and Tom engage with Elaine Chang from the FDA to discuss an analysis of depth of response as an indicator of …
8 months, 3 weeks ago
Episode 474: Uromigos Shorts - IO-refractory Urothelial Cancer
In this episode of the Uromigos podcast, Brian Rini, Tom Powles, and Karine Tawagi discuss the complexities of immunotherapy re-challenge in bladder …
8 months, 4 weeks ago